Transcatheter Pulmonary Valve Market To Reach $100.6 Million By 2030

Transcatheter Pulmonary Valve Market Growth & Trends

The global transcatheter pulmonary valve market size is expected to reach USD 100.6 million by 2030, registering to grow at a CAGR of 5.5% from 2024 to 2030 according to a new report by Grand View Research, Inc. The technological advancements pertaining to heart valve technologies, and increasing number of clinical trials pipeline by various public and private players are some of the crucial factors expected to boost the market over the forecast period.

In 2023, North America held the majority of market share of nearly 80.6% in the global market. Some of the major drivers are increasing prevalence of the various cardiovascular disorders, growing geriatric population with heart valve diseases such as pulmonary stenosis, pulmonary regurgitation, and others, and rising awareness regarding the benefits of transcatheter valves over surgical procedures. The growing number of patients suffering from long-term heart disorders, rising awareness about technologically advanced heart valve, and increasing healthcare expenditures and reimbursement policies for overall transcatheter valves are some of the key contributors to the growth of the market globally.

However, Asia Pacific is expected to show a growth in this market after 2019, as there will be several product launch in this region. The Asia Pacific region is expected to grow at a lucrative growth rate owing to the growth of many developing economies like Japan and China. These developing countries show a potential of growth due to various contributors such as the increasing aging population and growing prevalence of heart diseases. Moreover, the presence of a large pool of patients, developing healthcare infrastructure & services, increasing disposable income, and rising government funding are some of the factors that are expected to drive the market during the forecast period.

 Request a free sample copy or view report summary: Transcatheter Pulmonary Valve Market Report

Transcatheter Pulmonary Valve Market Report Highlights

• Pulmonary stenosis dominated the market and accounted for a market share of 43.1% in 2023. TPV operations are less invasive in nature compared to open-heart surgery.

• In 2023, balloon transcatheter valve segment held majority of the revenue share and is expected to be the fastest growing transcatheter pulmonary valve market during the forecast period

• Some of the key players are Boston Scientific Corporation, Braile Biomédica, Direct Flow Medical, Edwards Lifesciences Corporation, JenaValve Technology, Inc., St. Jude Medical, and VENUS MEDTECH.

Transcatheter Pulmonary Valve Market Segmentation

Grand View Research has segmented the global transcatheter pulmonary valve market based on application, technology, end-use, raw material, and region

Transcatheter Pulmonary Valve  Application Outlook (Revenue, USD Million, 2018 - 2030)

• Pulmonary Stenosis

• Pulmonary Regurgitation

• Pulmonary Atresia

• Others

Transcatheter Pulmonary Valve  Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Ballon Expanded Transcatheter Valve

• Self Expanded Transcatheter Valve

Transcatheter Pulmonary Valve  End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Adult

• Pediatric

Transcatheter Pulmonary Valve  Raw Material Outlook (Revenue, USD Million, 2018 - 2030)

• Synthetic

• Tissue Engineered

Transcatheter Pulmonary Valve  Regional Outlook (Revenue, USD Million; 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • Germany

  • UK

  • France

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

• Latin America

  • Brazil

  • Mexico

• Middle East and Africa (MEA)

  • KSA

  • UAE

  • South Africa

List of Key Players in Transcatheter Pulmonary Valve Market

• Boston Scientific Corporation

• Braile Biomedica

• Artivion, Inc

• Edwards Lifesciences Corporation

• JenaValve Technology, Inc

• LivaNova PLC

• Medtronic

• Venus Medtech

• Lepu Medical Technology

• Jude Medical Inc